DENTSPLY SIRONA (NASDAQ:XRAY) PT Lowered to $28.00

DENTSPLY SIRONA (NASDAQ:XRAY) had its price target cut by investment analysts at Evercore ISI from $35.00 to $28.00 in a research note issued on Tuesday, Benzinga reports. The brokerage presently has an “outperform” rating on the medical instruments supplier’s stock. Evercore ISI’s target price suggests a potential upside of 11.29% from the stock’s current price.

A number of other research firms have also recently commented on XRAY. SVB Leerink started coverage on DENTSPLY SIRONA in a research report on Monday, February 26th. They set an “outperform” rating and a $42.00 price objective for the company. StockNews.com cut DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a research report on Friday, May 3rd. The Goldman Sachs Group cut their target price on DENTSPLY SIRONA from $34.00 to $30.00 and set a “neutral” rating for the company in a research report on Monday, May 6th. Robert W. Baird cut their target price on DENTSPLY SIRONA from $35.00 to $33.00 and set a “neutral” rating for the company in a research report on Friday, May 3rd. Finally, Needham & Company LLC cut their target price on DENTSPLY SIRONA from $42.00 to $36.00 and set a “buy” rating for the company in a research report on Friday, May 3rd. Five analysts have rated the stock with a hold rating and seven have given a buy rating to the company. According to MarketBeat.com, DENTSPLY SIRONA has an average rating of “Moderate Buy” and a consensus price target of $34.44.

DENTSPLY SIRONA Trading Up 0.6 %

DENTSPLY SIRONA stock opened at $25.16 on Tuesday. The company has a current ratio of 1.43, a quick ratio of 0.97 and a debt-to-equity ratio of 0.54. The business’s fifty day simple moving average is $27.94 and its two-hundred day simple moving average is $31.81. DENTSPLY SIRONA has a 12 month low of $24.82 and a 12 month high of $41.65. The company has a market capitalization of $5.22 billion, a price-to-earnings ratio of -57.18, a price-to-earnings-growth ratio of 1.12 and a beta of 1.04.

DENTSPLY SIRONA (NASDAQ:XRAY) last announced its quarterly earnings results on Thursday, May 2nd. The medical instruments supplier reported $0.42 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.42. The firm had revenue of $953.00 million for the quarter, compared to the consensus estimate of $969.45 million. DENTSPLY SIRONA had a positive return on equity of 11.54% and a negative net margin of 2.41%. The company’s quarterly revenue was down 2.6% on a year-over-year basis. During the same period in the prior year, the company posted $0.39 earnings per share. As a group, equities analysts predict that DENTSPLY SIRONA will post 2.02 earnings per share for the current fiscal year.

Insider Activity

In other DENTSPLY SIRONA news, Director Gregory T. Lucier purchased 3,577 shares of DENTSPLY SIRONA stock in a transaction dated Friday, May 31st. The shares were purchased at an average cost of $27.95 per share, for a total transaction of $99,977.15. Following the completion of the acquisition, the director now owns 58,374 shares in the company, valued at approximately $1,631,553.30. The acquisition was disclosed in a document filed with the SEC, which is available at this hyperlink. Corporate insiders own 0.52% of the company’s stock.

Institutional Investors Weigh In On DENTSPLY SIRONA

Hedge funds and other institutional investors have recently modified their holdings of the business. Verity Asset Management Inc. purchased a new position in shares of DENTSPLY SIRONA in the 1st quarter valued at $294,000. Teachers Retirement System of The State of Kentucky lifted its position in DENTSPLY SIRONA by 6.2% during the 1st quarter. Teachers Retirement System of The State of Kentucky now owns 19,370 shares of the medical instruments supplier’s stock worth $642,000 after acquiring an additional 1,130 shares during the period. Cetera Advisors LLC lifted its position in DENTSPLY SIRONA by 18.6% during the 1st quarter. Cetera Advisors LLC now owns 17,052 shares of the medical instruments supplier’s stock worth $566,000 after acquiring an additional 2,675 shares during the period. Virtu Financial LLC acquired a new stake in DENTSPLY SIRONA during the 1st quarter worth about $1,027,000. Finally, Comerica Bank lifted its position in DENTSPLY SIRONA by 2.9% during the 1st quarter. Comerica Bank now owns 42,568 shares of the medical instruments supplier’s stock worth $1,413,000 after acquiring an additional 1,205 shares during the period. 95.70% of the stock is currently owned by hedge funds and other institutional investors.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.